Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3680
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06663137 | A Study to Evaluate the Safety and Efficacy of NDV-01 in Participants With NMIBC | ||
| NCT06964230 | A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects | ||
| NCT02935699 | Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria | ||
| NCT00226421 | Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain | ||
| NCT04033432 | sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer | ||
| NCT03054363 | Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer | ||
| NCT03271021 | A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris | ||
| NCT02178098 | Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension | ||
| NCT03896009 | Maximizing Outcomes in Treating Acute Migraine | ||
| NCT07714395 | Evaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With Advanced Solid Tumors | ||
| NCT03212404 | Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers | ||
| NCT02510599 | Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis | ||
| NCT00043836 | The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure | ||
| NCT01829971 | A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection | ||
| NCT01978964 | Phase 1b Maintenance Therapy Study of ONT-10 in Patients With Solid Tumors | ||
| NCT06597799 | First-in-human Study of MRT-6160 in Healthy Subjects | ||
| NCT06698939 | ORKA-001 in Healthy Volunteers | ||
| NCT01455844 | TRIal For Efficacy of Capre on hyperTriglyceridemiA | ||
| NCT06624644 | A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma | ||
| NCT07160790 | Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease | ||
| NCT06433752 | A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS) | ||
| NCT05798897 | Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma | ||
| NCT00635089 | Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis | ||
| NCT01478178 | Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma | ||
| NCT00880490 | Study to Evaluate the Safety and Efficacy of Inhaled PT005 in Patients With Chronic Obstructive Pulmonary Disease (COPD) | ||
| NCT01984684 | Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections | ||
| NCT05279417 | ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA) | ||
| NCT04440410 | Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atopic Dermatitis | ||
| NCT03748706 | PTI-125 for Mild-to-moderate Alzheimer's Disease Patients | ||
| NCT04610047 | Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness | ||
| NCT02944448 | A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee | ||
| NCT03301597 | NLA101 in Adults Receiving High Dose Chemotherapy for AML | ||
| NCT07681076 | Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers | ||
| NCT07447817 | Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias | ||
| NCT02268851 | A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL | ||
| NCT01701323 | Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT06018766 | LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome. | ||
| NCT04112446 | Study to Evaluate Absorption, Metabolism and Excretion of Single-dose [14C]-Saroglitazar in Healthy Male Subjects | ||
| NCT01636141 | Phase 1 Safety Study of Single and Multi-Dose Topically Applied OLT1177 Gel in Healthy Subjects | ||
| NCT06615557 | Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4) | ||
| NCT01460654 | Testosterone and Alendronate in Hypogonadal Men | ||
| NCT06263231 | A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3) | ||
| NCT00757783 | Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment | ||
| NCT03993873 | Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET | ||
| NCT04535531 | A Phase 3 Molluscum Contagiosum Efficacy and Safety Study | ||
| NCT07634601 | Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer | ||
| NCT05877066 | Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture | ||
| NCT07030439 | A Bioequivalence Study to Compare Senaparib Manufactured at 2 Sites in Healthy Subjects in Fasting State | ||
| NCT04504383 | PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC) | ||
| NCT03108066 | MK-3795 (PT2385) for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma (MK-3795-003) |
